Lindor KD - Search Results

1

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.

Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Hirschfield GM, Parés A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Lammers WJ, Hansen BE, van der Meer AJ. Harms MH, et al. Among authors: lindor kd. J Hepatol. 2019 Aug;71(2):357-365. doi: 10.1016/j.jhep.2019.04.001. Epub 2019 Apr 11. J Hepatol. 2019. PMID: 30980847

2

Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?

Crippin JS, Lindor KD, Jorgensen R, Kottke BA, Harrison JM, Murtaugh PA, Dickson ER. Crippin JS, et al. Among authors: lindor kd. Hepatology. 1992 May;15(5):858-62. doi: 10.1002/hep.1840150518. Hepatology. 1992. PMID: 1568727 Clinical Trial.

3

The metabolic bone disease of primary sclerosing cholangitis.

Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RA, LaRusso NF. Hay JE, et al. Among authors: lindor kd. Hepatology. 1991 Aug;14(2):257-61. Hepatology. 1991. PMID: 1860683

4

The combination of prednisone and colchicine in patients with primary sclerosing cholangitis.

Lindor KD, Wiesner RH, Colwell LJ, Steiner B, Beaver S, LaRusso NF. Lindor KD, et al. Am J Gastroenterol. 1991 Jan;86(1):57-61. Am J Gastroenterol. 1991. PMID: 1986556 Clinical Trial.

5

Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study.

Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Balasubramaniam K, et al. Among authors: lindor kd. Gastroenterology. 1990 Jun;98(6):1567-71. doi: 10.1016/0016-5085(90)91091-j. Gastroenterology. 1990. PMID: 2338193

6

The autologous mixed lymphocyte reaction in primary biliary cirrhosis: analysis of activation and blastogenesis of autoreactive T lymphocytes.

Lindor KD, Wiesner RH, Dickson ER, Homburger HA. Lindor KD, et al. Hepatology. 1988 Nov-Dec;8(6):1555-9. doi: 10.1002/hep.1840080614. Hepatology. 1988. PMID: 3263933

7

Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis.

Wiesner RH, Grambsch PM, Lindor KD, Ludwig J, Dickson ER. Wiesner RH, et al. Among authors: lindor kd. Hepatology. 1988 May-Jun;8(3):668-76. doi: 10.1002/hep.1840080339. Hepatology. 1988. PMID: 3286461 Review.

8

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study.

Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, Lange SM, Rossi SS, Hofmann AF, Baldus WP. Lindor KD, et al. Hepatology. 1995 Oct;22(4 Pt 1):1158-62. doi: 10.1016/0270-9139(95)90624-x. Hepatology. 1995. PMID: 7557866 Clinical Trial.

9

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

Jorgensen RA, Dickson ER, Hofmann AF, Rossi SS, Lindor KD. Jorgensen RA, et al. Among authors: lindor kd. Gut. 1995 Jun;36(6):935-8. doi: 10.1136/gut.36.6.935. Gut. 1995. PMID: 7615288 Free PMC article. Clinical Trial.

10

Primary biliary cirrhosis.

Laurin JM, Lindor KD. Laurin JM, et al. Among authors: lindor kd. Dig Dis. 1994 Nov-Dec;12(6):331-50. doi: 10.1159/000171469. Dig Dis. 1994. PMID: 7712616 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters